Print Print    Close Close

Road warriors: Rangers beat Blue Jays to take Game 1 of ALDS

By ,

Published October 08, 2015

FoxSports
13464db9-

Rougned Odor #12 of the Texas Rangers celebrates with teammate Elvis Andrus #1 after scoring a solo home run against David Price #14 of the Toronto Blue Jays in the seventh inning during game one of the American League Division Series at Rogers Centre on October 8, 2015 in Toronto, Ontario, Canada. (Photo by Tom Szczerbowski/Getty Images)

Robinson Chirinos hit a two-run homer against David Price, Rougned Odor had a solo shot and the Texas Rangers beat the Blue Jays 5-3 on Thursday in an AL Division Series opener as postseason baseball returned to Toronto for the first time in 22 years.

Both starting third baseman left with injuries: Texas' Adrian Beltre in the third with a sore lower back and Toronto's Josh Donaldson in the fifth after he was kneed in the head while sliding in an attempt to break up a double play.

Yovani Gallardo (1-0) allowed two runs and four hits in five innings, improving to 4-0 with a 1.78 ERA in four career starts against Toronto. Keone Kela, Jake Diekman and Sam Dyson finished, with Dyson getting a save.

Pitching on 11 days' rest, Price (0-1) allowed five runs and five hits in seven innings. He dropped to 1-6 with a 4.79 ERA in 11 postseason games, including six starts.

Print Print    Close Close

URL

https://www.foxnews.com/sports/road-warriors-rangers-beat-blue-jays-to-take-game-1-of-alds

  • Home
  • Video
  • Politics
  • U.S.
  • Opinion
  • Entertainment
  • Tech
  • Science
  • Health
  • Travel
  • Lifestyle
  • World
  • Sports
  • Weather
  • Privacy
  • Terms

This material may not be published, broadcast, rewritten, or redistributed. © FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.Do Not Sell my Personal Information - New Terms of Use - FAQ